Piramal Group's PE arm to raise Rs 1,000-cr health care fund

The first closure of Rs 250-300 crore is expected by March 2013

Image
Reghu Balakrishnan Mumbai
Last Updated : Jan 21 2013 | 5:46 PM IST

India Venture Advisors, the private equity arm of Piramal Enterprises Ltd, is set to raise a Rs 1,000-crore health care-focused fund. The Rs 500-crore fund, with an over-allotment of Rs 500 crore, will be launched officially within a month.

India Venture, founded in 2007 by Ajay Piramal and A K Purwar, former chairman of State Bank of India, has its focus on health care and life sciences investments.

The fund, India Venture Advisors Fund II, will be raised from domestic investors and will see deals in the range of Rs 30-70 crore.
 

DEAL SUMMARY
PE/ VC deals in pharma & health care
Sub-industryDeal
volume
Deal value
 
($mn)
Biotechnology10.25
Health care equipment796.11
Health care facilities10411.73
Health care services12241.94
Pharmaceuticals7101.42
Others5110.55
Total42962.00
Figures till 2012, year to date                         Source:VCCedge

“We are yet to finish the formalities of registration with Sebi (Securities and Exchange Board of India) and we expect to launch the fund officially in a month,“ said Purwar, chairman of India Venture. According to him, the first closure of Rs 250-300 crore is expected by March 2013. The firm had launched the Rs 400-crore India Venture Advisors Fund II in 2009 and has made about six investments so far. The fund will make its final investment in a couple of weeks, Purwar said.

The first fund will start exiting investments by early next year. “We are not in a hurry as we have time till 2016 with a seven-year fund life,” he added.

Its investments include $19 million (Rs 104 crore today) in Trichy-based Kavery Medical Centre and Hospital, Rs 70-crore in Chandigarh-based Vardhman Chemtech Ltd and an undisclosed amount in pharmacy chain- Medplus.

According to data from VCCedge, the pharma and health care sector in India has witnessed 239 deals in the last five years worth $4.6 billion. Of which, the area of health care facilities saw 61 deals worth $1.4 billion, while the health care services space witnessed 50 deals worth $2 billion since 2007. In all, 53 deals worth $700 million have taken place in the pharmaceutical sector in the last five years. India Venture had reportedly made two investments in non-health care areas.

It had invested Rs 40 crore in Sangli-based manufacturer of ductile iron castings, Tulsi Castings and Machining, and another Rs 50 crore in Gurgaon-based infrastructure player C&C Constructions Ltd.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 15 2012 | 12:00 AM IST

Next Story